ES2912785T3 - Catéteres ureterales y vesicales y métodos de inducción de presión negativa para aumentar la perfusión renal - Google Patents
Catéteres ureterales y vesicales y métodos de inducción de presión negativa para aumentar la perfusión renal Download PDFInfo
- Publication number
- ES2912785T3 ES2912785T3 ES18791406T ES18791406T ES2912785T3 ES 2912785 T3 ES2912785 T3 ES 2912785T3 ES 18791406 T ES18791406 T ES 18791406T ES 18791406 T ES18791406 T ES 18791406T ES 2912785 T3 ES2912785 T3 ES 2912785T3
- Authority
- ES
- Spain
- Prior art keywords
- tube
- catheter
- patient
- ureteral
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title description 42
- 230000010412 perfusion Effects 0.000 title description 9
- 230000006698 induction Effects 0.000 title description 7
- 210000003734 kidney Anatomy 0.000 claims abstract description 185
- 239000012530 fluid Substances 0.000 claims abstract description 119
- 210000000626 ureter Anatomy 0.000 claims abstract description 97
- 210000000244 kidney pelvis Anatomy 0.000 claims abstract description 95
- 230000014759 maintenance of location Effects 0.000 claims abstract description 84
- 239000000463 material Substances 0.000 claims description 34
- 210000001635 urinary tract Anatomy 0.000 claims description 32
- 238000004891 communication Methods 0.000 claims description 14
- 230000001939 inductive effect Effects 0.000 claims description 10
- 210000003932 urinary bladder Anatomy 0.000 description 170
- 210000002700 urine Anatomy 0.000 description 137
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 44
- 210000004369 blood Anatomy 0.000 description 32
- 239000008280 blood Substances 0.000 description 32
- 210000005239 tubule Anatomy 0.000 description 26
- 238000005534 hematocrit Methods 0.000 description 25
- 229940109239 creatinine Drugs 0.000 description 22
- 210000003708 urethra Anatomy 0.000 description 22
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 19
- 239000011734 sodium Substances 0.000 description 19
- 229910052708 sodium Inorganic materials 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 18
- 230000002485 urinary effect Effects 0.000 description 17
- 208000033626 Renal failure acute Diseases 0.000 description 15
- 201000011040 acute kidney failure Diseases 0.000 description 15
- 238000002560 therapeutic procedure Methods 0.000 description 15
- 208000009304 Acute Kidney Injury Diseases 0.000 description 14
- 238000001914 filtration Methods 0.000 description 13
- 238000002637 fluid replacement therapy Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 210000001631 vena cava inferior Anatomy 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 230000037396 body weight Effects 0.000 description 11
- 230000003907 kidney function Effects 0.000 description 10
- 210000000885 nephron Anatomy 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 206010059484 Haemodilution Diseases 0.000 description 9
- 206010020565 Hyperaemia Diseases 0.000 description 9
- 230000002706 hydrostatic effect Effects 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 230000009724 venous congestion Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000012781 shape memory material Substances 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 206010019280 Heart failures Diseases 0.000 description 7
- 210000002565 arteriole Anatomy 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- -1 polyethylene Polymers 0.000 description 7
- 230000009103 reabsorption Effects 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 206010016803 Fluid overload Diseases 0.000 description 6
- 241000282887 Suidae Species 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000004323 axial length Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000004276 hyalin Anatomy 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 206010016807 Fluid retention Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 239000012491 analyte Substances 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 230000000712 assembly Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 210000001736 capillary Anatomy 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000005484 gravity Effects 0.000 description 5
- 210000005084 renal tissue Anatomy 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 206010021143 Hypoxia Diseases 0.000 description 4
- 230000009056 active transport Effects 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000000004 hemodynamic effect Effects 0.000 description 4
- 210000000210 loop of henle Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 4
- 230000008855 peristalsis Effects 0.000 description 4
- 230000002572 peristaltic effect Effects 0.000 description 4
- 229920000915 polyvinyl chloride Polymers 0.000 description 4
- 239000004800 polyvinyl chloride Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 206010007556 Cardiac failure acute Diseases 0.000 description 3
- 208000004990 Cardiorenal syndrome Diseases 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000001926 lymphatic effect Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- 210000004197 pelvis Anatomy 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 230000002407 ATP formation Effects 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 206010041277 Sodium retention Diseases 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000002665 bowman capsule Anatomy 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000018875 hypoxemia Diseases 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- ZHVLGOLHHYJSBZ-QRPNPIFTSA-N (2s)-1-phenylpropan-2-amine;phosphoric acid Chemical compound OP(O)(O)=O.C[C@H](N)CC1=CC=CC=C1 ZHVLGOLHHYJSBZ-QRPNPIFTSA-N 0.000 description 1
- 206010058808 Abdominal compartment syndrome Diseases 0.000 description 1
- 102000008873 Angiotensin II receptor Human genes 0.000 description 1
- 108050000824 Angiotensin II receptor Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020524 Hydronephrosis Diseases 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 208000002623 Intra-Abdominal Hypertension Diseases 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000013156 embolectomy Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 210000001282 glomerular podocyte Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- DDLIGBOFAVUZHB-UHFFFAOYSA-N midazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F DDLIGBOFAVUZHB-UHFFFAOYSA-N 0.000 description 1
- 229960003793 midazolam Drugs 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000009057 passive transport Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000000557 podocyte Anatomy 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000012495 positive regulation of renal sodium excretion Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229960004134 propofol Drugs 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- 210000000512 proximal kidney tubule Anatomy 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000021023 sodium intake Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000004148 unit process Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000003202 urodynamic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
- A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
- A61M27/008—Implant devices for drainage of body fluids from one part of the body to another pre-shaped, for use in the urethral or ureteral tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/047—Urethrae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/73—Suction drainage systems comprising sensors or indicators for physical values
- A61M1/732—Visual indicating means for vacuum pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/78—Means for preventing overflow or contamination of the pumping systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
- A61M1/87—Details of the aspiration tip, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1082—Kidney
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1085—Bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- External Artificial Organs (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762489831P | 2017-04-25 | 2017-04-25 | |
| US201762489789P | 2017-04-25 | 2017-04-25 | |
| US15/687,064 US10765834B2 (en) | 2015-07-20 | 2017-08-25 | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US15/687,083 US10926062B2 (en) | 2015-07-20 | 2017-08-25 | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US201815745823A | 2018-01-18 | 2018-01-18 | |
| PCT/US2018/015282 WO2018200052A1 (en) | 2017-04-25 | 2018-01-25 | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2912785T3 true ES2912785T3 (es) | 2022-05-27 |
Family
ID=63918653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18791406T Active ES2912785T3 (es) | 2017-04-25 | 2018-01-25 | Catéteres ureterales y vesicales y métodos de inducción de presión negativa para aumentar la perfusión renal |
Country Status (6)
| Country | Link |
|---|---|
| EP (4) | EP3615125A4 (enExample) |
| JP (2) | JP2020517359A (enExample) |
| CN (2) | CN110785201A (enExample) |
| BR (1) | BR112019022400A2 (enExample) |
| ES (1) | ES2912785T3 (enExample) |
| WO (3) | WO2018200051A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10512713B2 (en) | 2015-07-20 | 2019-12-24 | Strataca Systems Limited | Method of removing excess fluid from a patient with hemodilution |
| US10493232B2 (en) | 2015-07-20 | 2019-12-03 | Strataca Systems Limited | Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function |
| CA3032266C (en) | 2015-07-20 | 2022-05-10 | Strataca Systems Limited | Ureteral and bladder catheters and methods for inducing negative pressure to increase renal perfusion |
| US11541205B2 (en) | 2015-07-20 | 2023-01-03 | Roivios Limited | Coated urinary catheter or ureteral stent and method |
| US11229771B2 (en) | 2015-07-20 | 2022-01-25 | Roivios Limited | Percutaneous ureteral catheter |
| US11040180B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Systems, kits and methods for inducing negative pressure to increase renal function |
| US10926062B2 (en) | 2015-07-20 | 2021-02-23 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US10765834B2 (en) | 2015-07-20 | 2020-09-08 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| US12064567B2 (en) | 2015-07-20 | 2024-08-20 | Roivios Limited | Percutaneous urinary catheter |
| US10918827B2 (en) | 2015-07-20 | 2021-02-16 | Strataca Systems Limited | Catheter device and method for inducing negative pressure in a patient's bladder |
| US11040172B2 (en) | 2015-07-20 | 2021-06-22 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| CN115120791A (zh) | 2017-08-25 | 2022-09-30 | 罗维奥斯有限公司 | 促进从尿道除尿的排尿泵 |
| PT3883630T (pt) * | 2018-11-21 | 2023-11-15 | Coloplast As | Cateter urinário intermitente |
| WO2020110049A1 (en) * | 2018-11-30 | 2020-06-04 | Strataca Systems Limited | Coated and/or impregnated ureteral catheter or stent and method |
| CN113395988B (zh) * | 2019-02-08 | 2023-03-31 | 科洛普拉斯特公司 | 导尿管 |
| EP3718593B1 (en) * | 2019-04-02 | 2022-12-14 | Universität Regensburg - Universitätsklinikum | Transurethral catheter device for bleeding control in pelvic fractures |
| US11628271B2 (en) * | 2019-06-10 | 2023-04-18 | Spinal Singularity, Inc. | Urinary catheter |
| CN111249045B (zh) * | 2020-01-17 | 2021-09-21 | 浙江医高医疗科技有限公司 | 改良的输尿管支架系统及其置入方法 |
| US20210370019A1 (en) * | 2020-05-28 | 2021-12-02 | Strataca Systems Limited | Method of Treatment Using Negative Pressure Renal Therapy and Medicament(s) |
| GB2603124B (en) * | 2021-01-22 | 2024-08-14 | Cambridge Univ Hospitals Nhs Foundation Trust | Vacuum Therapy Devices and Methods |
| WO2022216776A1 (en) * | 2021-04-09 | 2022-10-13 | Purewick Corporation | Conduits including at least one conduit porous material |
| US12472301B2 (en) | 2021-08-13 | 2025-11-18 | 3Ive Labs, Llc | Negative pressure therapy system and methods |
| CN114404780A (zh) * | 2022-01-24 | 2022-04-29 | 成都维宁生物技术有限公司 | 无囊防漏留置导尿管及其制造方法和用途 |
| CN114558179A (zh) * | 2022-03-04 | 2022-05-31 | 成都莫瑞克生物技术有限公司 | 自开式瓣状导尿管及其制造方法和用途 |
| US20230364322A1 (en) * | 2022-05-10 | 2023-11-16 | Roivios Limited | Wearable Garment for Negative Pressure Therapy |
| CN117282001A (zh) * | 2022-06-17 | 2023-12-26 | 上海交通大学医学院附属仁济医院 | 一种用于泌尿科的多药物涂层抗肿瘤的输尿管支架 |
| WO2024062218A1 (en) * | 2022-09-20 | 2024-03-28 | Convatec Limited | A catheter |
| CN116370805A (zh) * | 2023-04-20 | 2023-07-04 | 山东威高集团医用高分子制品股份有限公司 | 一种输尿管支架及支架放置套装 |
| CN119701112B (zh) * | 2025-02-28 | 2025-06-06 | 复旦大学 | 一种淋巴引流装置 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3397699A (en) * | 1966-05-05 | 1968-08-20 | Gerald C. Kohl | Retaining catheter having resiliently biased wing flanges |
| US5562622A (en) * | 1995-03-20 | 1996-10-08 | Contimed, Inc. | Self-cleansing bladder drainage device |
| US6500158B1 (en) * | 1997-03-26 | 2002-12-31 | The Trustees Of Columbia University In The City Of New York | Method of inducing negative pressure in the urinary collecting system and apparatus therefor |
| US6332892B1 (en) * | 1999-03-02 | 2001-12-25 | Scimed Life Systems, Inc. | Medical device with one or more helical coils |
| US6709465B2 (en) | 1999-03-18 | 2004-03-23 | Fossa Medical, Inc. | Radially expanding ureteral device |
| US6558350B1 (en) * | 2000-06-20 | 2003-05-06 | Applied Medical Resources Corp. | Drainage catheter |
| ES2551521T3 (es) * | 2000-12-11 | 2015-11-19 | Orbusneich Medical, Inc. | Endoprótesis que tiene elementos helicoidales |
| US8506647B2 (en) * | 2002-02-14 | 2013-08-13 | Boston Scientific Scimed, Inc. | System for maintaining body canal patency |
| CN2588940Y (zh) * | 2002-10-31 | 2003-12-03 | 上海富士能高内镜有限公司 | 一种扩张吸引器 |
| US20060271019A1 (en) * | 2004-10-15 | 2006-11-30 | The Regents Of The University Of California | Drainage system |
| US7931630B2 (en) * | 2005-07-05 | 2011-04-26 | C. R. Bard, Inc. | Multi-functional and modular urine collection system |
| JP5226515B2 (ja) * | 2005-08-31 | 2013-07-03 | クック メディカル テクノロジーズ エルエルシー | アクセスキット |
| US8871869B2 (en) | 2005-12-09 | 2014-10-28 | Dsm Ip Assets B.V. | Hydrophilic coating |
| US20080255550A1 (en) * | 2006-11-30 | 2008-10-16 | Minos Medical | Systems and methods for less invasive neutralization by ablation of tissue including the appendix and gall bladder |
| US20090105719A1 (en) * | 2007-10-19 | 2009-04-23 | Vance Products Incorporated, D/B/A Cook Urological Incorporated | Precision stent positioner |
| CN100548245C (zh) * | 2007-12-21 | 2009-10-14 | 山东大学 | 微创负压膀胱穿刺造瘘留置装置及其工作方法 |
| EP2349081B1 (en) * | 2008-10-10 | 2024-12-11 | Implantica Patent Ltd. | Implantable device for internal urinary control |
| DK2387383T3 (en) * | 2009-01-18 | 2017-07-10 | Ocon Medical Ltd | HOW TO UNKNOWN INTRAUTERIN DEVICE |
| JP2014508580A (ja) * | 2011-01-19 | 2014-04-10 | フラクティル ラボラトリーズ インコーポレイテッド | 組織の治療のためのデバイスおよび方法 |
| EP3398539B1 (en) * | 2011-05-23 | 2020-08-26 | Covidien LP | Retrieval systems |
| US9132040B2 (en) * | 2011-11-17 | 2015-09-15 | Ethicon, Inc. | Dressing device |
| EP2749309B1 (en) * | 2012-12-28 | 2016-04-27 | Cook Medical Technologies LLC | Ion exchange ureteral stent |
| AU2015243533A1 (en) * | 2014-04-10 | 2016-10-27 | C.R. Bard, Inc. | Ureteral stents |
| JP2017520377A (ja) * | 2014-06-27 | 2017-07-27 | ウロゲン ファーマ リミテッド | 接続可能カテーテル |
| CN204246651U (zh) * | 2014-11-17 | 2015-04-08 | 江苏省人民医院 | 一种易于置换的输尿管支架管 |
| CN205126495U (zh) * | 2015-07-14 | 2016-04-06 | 王洛 | 多分支管肠道套接组件 |
| CA3032266C (en) | 2015-07-20 | 2022-05-10 | Strataca Systems Limited | Ureteral and bladder catheters and methods for inducing negative pressure to increase renal perfusion |
| HK1248613A1 (zh) * | 2015-07-20 | 2018-10-19 | 罗维奥斯有限公司 | 在患者膀胱中引起负压的导管装置和方法 |
| US10765834B2 (en) | 2015-07-20 | 2020-09-08 | Strataca Systems Limited | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion |
| WO2017019974A1 (en) * | 2015-07-29 | 2017-02-02 | Renastent Llc | Transformable ureteral stent |
| CN106237417A (zh) * | 2016-05-19 | 2016-12-21 | 黄健 | 一种多功能灌注吸引平台及使用方法 |
| CN106473847A (zh) * | 2016-11-22 | 2017-03-08 | 曹庆杰 | 可降解的膨胀性局部尿路腔内支架系统 |
| ES2911641T3 (es) * | 2017-01-20 | 2022-05-20 | Roivios Ltd | Sistema para remover el exceso de fluido de un paciente con hemodilución |
-
2018
- 2018-01-25 BR BR112019022400A patent/BR112019022400A2/pt not_active Application Discontinuation
- 2018-01-25 EP EP18791301.7A patent/EP3615125A4/en not_active Withdrawn
- 2018-01-25 EP EP18791406.4A patent/EP3600146B1/en active Active
- 2018-01-25 WO PCT/US2018/015271 patent/WO2018200051A1/en not_active Ceased
- 2018-01-25 EP EP18790948.6A patent/EP3614963A4/en active Pending
- 2018-01-25 JP JP2019557555A patent/JP2020517359A/ja active Pending
- 2018-01-25 WO PCT/US2018/015260 patent/WO2018200050A1/en not_active Ceased
- 2018-01-25 CN CN201880042008.0A patent/CN110785201A/zh active Pending
- 2018-01-25 CN CN201880027590.3A patent/CN110636816A/zh active Pending
- 2018-01-25 EP EP22152135.4A patent/EP4008372A1/en not_active Withdrawn
- 2018-01-25 ES ES18791406T patent/ES2912785T3/es active Active
- 2018-01-25 JP JP2019557576A patent/JP7084942B2/ja active Active
- 2018-01-25 WO PCT/US2018/015282 patent/WO2018200052A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3614963A4 (en) | 2021-01-13 |
| EP3600146A1 (en) | 2020-02-05 |
| CN110785201A (zh) | 2020-02-11 |
| JP2020517361A (ja) | 2020-06-18 |
| EP3615125A1 (en) | 2020-03-04 |
| WO2018200050A1 (en) | 2018-11-01 |
| WO2018200051A8 (en) | 2018-12-27 |
| BR112019022400A2 (pt) | 2020-05-19 |
| JP7084942B2 (ja) | 2022-06-15 |
| EP3600146A4 (en) | 2020-04-15 |
| WO2018200051A1 (en) | 2018-11-01 |
| WO2018200052A1 (en) | 2018-11-01 |
| JP2020517359A (ja) | 2020-06-18 |
| EP3614963A1 (en) | 2020-03-04 |
| EP4008372A1 (en) | 2022-06-08 |
| EP3600146B1 (en) | 2022-03-02 |
| EP3615125A4 (en) | 2021-01-20 |
| CN110636816A (zh) | 2019-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2912785T3 (es) | Catéteres ureterales y vesicales y métodos de inducción de presión negativa para aumentar la perfusión renal | |
| US12023459B2 (en) | Negative pressure therapy system | |
| US11904113B2 (en) | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion | |
| ES2911641T3 (es) | Sistema para remover el exceso de fluido de un paciente con hemodilución | |
| US10512713B2 (en) | Method of removing excess fluid from a patient with hemodilution | |
| US11918754B2 (en) | Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion | |
| US11752300B2 (en) | Catheter device and method for inducing negative pressure in a patient's bladder |